Cannvas MedTech (CSE:MTEC) (Frankfurt: 3CM) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce its senior team will travel to Lisbon to attend the 2018 Web Summit, Europe’s largest and most important technology marketplace. In addition to high-level networking with leading investors and CEOs from around the world, Cannvas will also present two booths related to their Cannvas.Me and Cannvas.Pet platforms, compete in pitch presentations and participate in mentoring sessions. This year’s Web Summit takes place November 5-6 at the Altice Arena in Portugal’s capital city.

“We are thrilled to be heading back to Web Summit with our team to grow awareness of our Cannvas.Me and Cannvas.Pet platforms, each providing credible information on the benefits of health care through cannabis for humans and our fuzzy little friends as well,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “We are looking forward to learning from other leaders across our industry and very excited at the prospect of this year’s PITCH competition where we are confident our data-driven solutions for the global cannabis community will turn some heads.”


PITCH is a startup competition at Web Summit open to any exhibiting startup that has received under €3 million (approx. $4.4 million CND) in funding to date. Cannvas MedTech will be one of 160 startups to present in front of distinguished investor panels, influential media and thousands of attendees as competitors look to secure funding and guidance from leading investors across the globe. The leadership team at Cannvas will also attend several mentoring sessions, a series of pre-scheduled, 15-minute meetings between high-level attendees and startups during which speakers, investors, partners and media give business advice to startups.

Cannvas will present two exhibits for attendees to learn more about their platforms Cannvas.Me and Cannvas.Pet. Cannvas.Me is a free unbiased educational resource for medicinal and adult-use cannabis users offering a comprehensive solution for the global cannabis community with physician-backed content and innovative tools for all audiences wishing to learn about health care through cannabis. Through technology and machine learning, Cannvas.Pet aims to become the online authority for pet owners to educate, track and improve the overall treatment of their furry loved ones.

“We have had the privilege of attending world-class technology conferences with considerable support from our friends at Tech West Canada and have leveraged this support to explore real opportunities and significantly grow our business,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc. “Tech West is known to provide early-stage tech companies like Cannvas with incredible strategic guidance and business development support at an international level, and they have been a valuable partner in helping introduce our patient-centric medical cannabis platform.”

Over the past year, Cannvas has been part of important delegations from Canada that were showcased by Tech West at three international trade events: Web Summit in Lisbon, Portugal, CES in Los Angeles, California and Mobile World Congress in Barcelona, Spain. On an annual basis Tech West promotes a team of innovative tech companies making a global impact at conferences around the world under a unified Canada brand.

About Web Summit
Web Summit has become “Europe’s largest and most important technology marketplace” – an unrivalled gathering of the world’s most disruptive technology companies and those harnessing their innovation to transform their businesses and their lives. World-class speakers, leading investors, and international media will come together for the ultimate startup gathering. Not to mention the CEOs of some of the most exciting companies and startups in the world. For more information, please visit www.websummit.com.

About Tech West Canada
Tech West Canada is funded by Western Economic Diversification Canada and is a flagship project of the ICT Association of Manitoba (ICTAM). By working in collaboration with the governments of Alberta, British Columbia, Manitoba and Saskatchewan, we are helping western Canadian technology companies go global. For more information: www.techwestcanada.ca.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation.

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less